Risk factors of severe pneumonia among children aged 2-59 months in western Kenya: a case control study

Dickens Onyango1, Gideon Kikuvi, Evans Amukoye

  • 1Field Epidemiology and Laboratory Management Training Program, Ministry of Public Health and Sanitation, Kenya.

Insights

Severe pneumonia in Kenyan children is linked to comorbidities, delayed treatment, and respiratory infections. Early antibiotic treatment at home showed protective effects against severe pneumonia in children under five.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pneumonia is a leading cause of under-five mortality globally and the second leading cause in Kenya.
  • Over 30,000 deaths annually in Kenya are attributed to pneumonia in children under five.
  • Identifying risk factors for severe pneumonia is crucial for targeted interventions.

Purpose of the Study:

  • To identify risk factors associated with severe pneumonia in children under five years of age in Kenya.

Main Methods:

  • A case-control study was conducted with 103 cases of severe/very severe pneumonia and 103 controls with non-severe pneumonia.
  • Data on socio-demographics, nutritional status, and environmental factors were collected via structured questionnaires.
  • Statistical analysis was performed using Epi Info with a significance level of 0.05.

Main Results:

  • Comorbidity (OR=3.8), delayed treatment (≥3 days) (OR=2.3), and upper respiratory tract infection (URTI) contact (OR=2.7) were significant risk factors for severe pneumonia.
  • Receiving antibiotics at home demonstrated a protective effect (OR=0.4).

Conclusions:

  • Comorbidity, URTI contact, and delayed healthcare seeking are key risk factors for severe childhood pneumonia.
  • Health education on appropriate healthcare seeking and community health worker engagement are recommended for prevention and control.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...